CLINICAL_TRIALS
trial_result
· 2019-01-23
Clinical Trial Update: Cytokine Induced Killer (CIK) Cells In Leukemia Patients [Phase 2]
Summary
A Phase 2 clinical trial evaluated Cytokine Induced Killer (CIK) cell therapy in leukemia; the study has completed and results were posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: A.O. Ospedale Papa Giovanni XXIII | Conditions: Hematologic Malignancies | Phase 2 | Status: COMPLETED | Results posted: 2019-01-23